Here we observed that the acute inhibition of SCD (∼95% reduction after 24 h treatment) with a specific small molecule inhibitor drastically reduced the rate of proliferation of a variety of human lung and breast cancer cell lines. The gene discussed is SCD; the disease is breast cancer.